stella
beta
Mavacamten Post-marketing Surveillance in Patients With Obstructive Hypertrophic Cardiomyopathy in Japan — Stella
Home
/
Obstructive Hypertrophic Cardiomyopathy (oHCM)
/
Mavacamten Post-marketing Surveillance in Patients With Obstructive Hypertrophic Cardiomyopathy in Japan
View on ClinicalTrials.gov
Recruiting
Back to Obstructive Hypertrophic Cardiomyopathy (oHCM) trials
Mavacamten Post-marketing Surveillance in Patients With Obstructive Hypertrophic Cardiomyopathy in Japan
Trial locations
(1 site)
Japan
CMIC Co., Ltd, Tokyo